Waisman Biomanufacturing

Clinical Production

GMP Protein Production

Waisman's recombinant protein process development and manufacturing services fully embrace our collaborative and flexible approach to product development. Our strength lies in the ability to develop a customized process that is reproducible and fully scalable, yielding an end product that meets industry standards for FDA submission, while meeting cost and timeline constraints and working as a true partner.

Protein Production Specifics

  • Wide variety of bacterial or mammalian host cells experience for production
  • Design of Experiment approach to initial screening and optimization
  • Automated chromatography and TFF skids to facilitate tech transfer and production of large product lots
  • Downstream processing expertise that includes column chromatography, protein refolding, tangential flow filtration, and microfiltration

Fermentation/Cell Culture Capabilities

  • 30 liter steam in-place fermentor
  • 50-250 liter single use bioreactor for suspension cells
  • Multi-tray Cell Factories for attachment dependent cells

Downstream Purification Capabilities

  • Cell harvest by continuous centrifugation or filtration
  • Cell lysis (chemical or mechanical methodologies)
  • Supernatant concentration / buffer exchange
  • Column chromatography
  • Protein refolding (100 liter chilled tank)
  • Tangential flow filtration (TFF)
  • Ultrafiltration

GMP Protein Production Highlights

  • Bacterial / mammalian hosts
  • Multiple bioreactors and multi-tray formats
  • Cell harvest by centrifuge or filtration
  • Protein refolding
  • Scalable downstream processing


Steam-In-Place Fermentation for Microbial-Based Protein Manufacturing